Last Friday, the federal government published its interim final rule that is 73 pages of government fine print. CMS is essentially requiring everyone who works in healthcare to become fully…
Read More
Now that a SARS-CoV-2 vaccine is authorized for children ages 5 to 11 years, state regulators—along with parents, pediatricians, and public health officials—are contemplating when and if the shots should…
The administration of President Joe Biden today announced the details of 2 policies covering more than 100 million workers in an effort to get more people vaccinated against COVID-19. The…
The FDA on October 29 authorized the emergency use of the Pfizer-BioNTech SARS-CoV-2 vaccine for children ages 5 to 11 years, making the vaccine the first to be authorized in…
The CDC updated its guidance on SARS-CoV-2 vaccine booster doses for people who are moderately or severely immunocompromised. Those individuals who received an initial 2-dose series with an mRNA vaccine…
The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously with one abstention to recommend the authorization of the Pfizer-BioNTech SARS-CoV-2 vaccine for children ages 5 to 11…
As expected, the FDA on October 20 authorized booster doses of the Moderna SARS-CoV-2 vaccine for certain populations and the J&J-Janssen vaccine for all recipients. The agency also authorized a…
According to an analysis published October 13 by the Peterson Center on Healthcare and the Kaiser Family Foundation, COVID-19 continues to be a leading cause of death in the US….
Echoing guidance by the CDC, England’s National Health Service (NHS England) on October 11 encouraged pregnant people to get vaccinated against SARS-CoV-2 and released data showing that, since July, nearly…
AstraZeneca on October 5 submitted a request to the FDA for an Emergency Use Authorization (EUA) of its investigational long-acting antibody combination drug AZD7442 for the prevention of symptomatic COVID-19….